The OIG report released June 15 details problems found during a January site visit, including lack of evidence of appropriate cleaning, lack of hand soap in the sterile compounding areas and undertrained employees.
None of the problems led to harm to patients, however. “None of the patients developed infections after intravenous infusions or injections of compounded medications,” according to the OIG report.
According to KSLA, the hospital’s pharmacy was closed to address the issues, but it has since reopened.
“Our patients did not experience any adverse events, interruption in care or impact to veterans’ access while we addressed the findings,” according to a statement sent to KSLA from Overton Brooks VA Medical Center.
More articles on patient safety:
Study: Power differential keeps residents from reporting unprofessional physician behavior
Investigation: Understaffing in OR contributed to 2 patient deaths at California hospital
100 patient safety benchmarks | 2017
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.